PharVision Advisers’s Coca-Cola KO Stock Holding History

PharVision Advisers’s Portfolio KO Stock Details KO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,612	Closed	-$253K	–	392
2025 Q4	$253K	Buy	3,612 +87	+2%	+$6.07K	0.13%	383
2025 Q3	$234K	Buy	+3,525	New	+$243K	0.13%	381

Other funds holding KO

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PharVision Advisers's KO Position: Q1 2026 in Review

PharVision Advisers sold out of Coca-Cola (KO) in Q1 2026, closing a stake of 3,612 shares — an estimated $253K sold.

PharVision Advisers first reported a position in KO in Q3 2025 and held it in 2 quarters. The position peaked at $253K in Q4 2025. 3,554 funds tracked by Wall St. Rank hold KO as of Q1 2026.

PharVision Advisers reported no remaining Coca-Cola position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 3,612 Coca-Cola shares in Q1 2026, an estimated $253K.
PharVision Advisers first reported a position in Coca-Cola in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Coca-Cola position peaked at $253K in Q4 2025.
3,554 funds tracked by Wall St. Rank held Coca-Cola as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.